DuoGenic StemCells (ROCO:7607) Total Long-Term Liabilities : NT$3.84 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. DuoGenic StemCells's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was NT$3.84 Mil.

DuoGenic StemCells Total Long-Term Liabilities Historical Data

The historical data trend for DuoGenic StemCells's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Total Long-Term Liabilities Chart

DuoGenic StemCells Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

0.69

1.64

5.23

3.84

DuoGenic StemCells Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Long-Term Liabilities	Get a 7-Day Free Trial			1.64	3.86	5.23	4.73	3.84

DuoGenic StemCells Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

DuoGenic StemCells Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN

Website

https://www.dgsc.com.tw

DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines